American Bio Medica Corporation（ABMC）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · ABMC · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2022-12	2021-12	2020-12	2019-12	2018-12
Revenue
Revenue	$0.91M	$2.22M	$4.15M	$3.65M	$3.87M
Cost of Revenue	$1.11M	$1.67M	$2.91M	$2.47M	$2.58M
Gross Profit	($0.19M)	$0.55M	$1.24M	$1.18M	$1.29M
Gross Margin %(computed)	-21.14%	24.71%	29.85%	32.39%	33.26%
Operating Expenses
R&D Expenses	$0.09M	$0.09M	$0.09M	$0.08M	$0.09M
G&A Expenses	$0.92M	$1.34M	$1.28M	$1.24M	$1.41M
Total Operating Expenses	$1.05M	$1.73M	$1.86M	$1.78M	$2.05M
Operating Income	($1.24M)	($1.18M)	($0.62M)	($0.59M)	($0.76M)
Operating Margin %(computed)	-136.04%	-53.16%	-14.97%	-16.22%	-19.68%
Interest Income	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
Interest Expense	$0.19M	$0.19M	$0.17M	$0.27M	$0.28M
Income Before Tax	($1.41M)	($0.46M)	($0.79M)	($0.69M)	($1.03M)
Income Tax Expense	$0.00M	$0.00M	$0.00M	($0.01M)	$0.00M
Net Income	($1.41M)	($0.46M)	($0.80M)	($0.68M)	($1.03M)
Net Margin %(computed)	-154.44%	-20.87%	-19.19%	-18.63%	-26.55%
Per Share & EBITDA
EPS (Basic)	$-0.03	$-0.01	$-0.02	$-0.02	$-0.03
Wtd Avg Shares	48.02M	42.76M	35.56M	32.53M	30.12M
EBITDA	($1.16M)	($0.20M)	($0.54M)	($0.34M)	($0.66M)
EBITDA Margin %(computed)	-127.38%	-8.97%	-13.02%	-9.30%	-17.07%